These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32627175)

  • 1. Micronuclei, dmin chromosomes and MYC amplifications as a singular presentation of myeloid malignancies.
    Montoro MJ; Rivero E; Teixidó M; Rodriguez Y; Chávez C; Salamero O; Navarrete M; Talavera E; Ortega M; Valcárcel D
    Br J Haematol; 2020 Oct; 191(1):e19-e22. PubMed ID: 32627175
    [No Abstract]   [Full Text] [Related]  

  • 2. Micronuclei-associated MYC amplification in the form of double minute chromosomes in acute myeloid leukemia.
    Yamamoto K; Okamura A; Sanada Y; Yakushijin K; Matsuoka H; Minami H
    Am J Hematol; 2013 Aug; 88(8):717-8. PubMed ID: 23456919
    [No Abstract]   [Full Text] [Related]  

  • 3. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
    Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
    Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).
    Visconte V; Tabarroki A; Zhang L; Hasrouni E; Gerace C; Frum R; Ai J; Advani AS; Duong HK; Kalaycio M; Saunthararajah Y; Sekeres MA; His ED; Shetty S; Rogers HJ; Tiu RV
    Am J Hematol; 2014 Aug; 89(8):862. PubMed ID: 24796269
    [No Abstract]   [Full Text] [Related]  

  • 5. MYC gene amplification in double minute chromosomes in an aggressive large B-cell lymphoma with leukemic presentation: a case report.
    Alseraye F; Padmore R; Wozniak M; McGowan-Jordan J
    Cancer Genet Cytogenet; 2009 Jul; 192(2):76-8. PubMed ID: 19596258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential B-lymphoid and myeloid blastic transformation of Philadelphia chromosome-negative myeloproliferative neoplasm.
    Hu AY; Zhou T
    Br J Haematol; 2019 Jan; 184(1):8. PubMed ID: 30407632
    [No Abstract]   [Full Text] [Related]  

  • 7. ZBTB44-FLT3 fusion in a patient with a myeloproliferative neoplasm.
    Zhou X; Yang C; Zou Z; Lang X; Chen P; Chen S; Wang K; Chen Y; Hao Y; Chen N; Ding J; Li Y; Shen Y; Xiao S
    Br J Haematol; 2020 Oct; 191(2):297-301. PubMed ID: 32866288
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomic analysis of myeloproliferative neoplasms in chronic and acute phases.
    Courtier F; Carbuccia N; Garnier S; Guille A; Adélaïde J; Cervera N; Gelsi-Boyer V; Mozziconacci MJ; Rey J; Vey N; Chaffanet M; Birnbaum D; Murati A
    Haematologica; 2017 Jan; 102(1):e11-e14. PubMed ID: 27742771
    [No Abstract]   [Full Text] [Related]  

  • 9. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
    Struski S; Luquet I
    Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375
    [No Abstract]   [Full Text] [Related]  

  • 10. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene.
    Storlazzi CT; Fioretos T; Surace C; Lonoce A; Mastrorilli A; Strömbeck B; D'Addabbo P; Iacovelli F; Minervini C; Aventin A; Dastugue N; Fonatsch C; Hagemeijer A; Jotterand M; Mühlematter D; Lafage-Pochitaloff M; Nguyen-Khac F; Schoch C; Slovak ML; Smith A; Solè F; Van Roy N; Johansson B; Rocchi M
    Hum Mol Genet; 2006 Mar; 15(6):933-42. PubMed ID: 16452126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet miR-28 expression level and thrombocytosis in MPN patients.
    Stolyar MA; Gorbenko AS; Olkhovskiy IA
    Int J Lab Hematol; 2019 Apr; 41(2):e43-e45. PubMed ID: 30480878
    [No Abstract]   [Full Text] [Related]  

  • 12. ZBTB7A links tumor metabolism to myeloid differentiation.
    Redondo Monte E; Kerbs P; Greif PA
    Exp Hematol; 2020 Jul; 87():20-24.e1. PubMed ID: 32525064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Notch disruption on myeloid development.
    Francis OL; Chaudhry KK; Lamprecht T; Klco JM
    Blood Cancer J; 2017 Aug; 7(8):e598. PubMed ID: 28841212
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myeloid leukemia with MYC amplification in the homogeneous staining regions and double minutes.
    Lee S; Kim M; Lim J; Kim Y; Han K; Kim HJ; Cho SG; Min WS
    Cancer Genet Cytogenet; 2009 Jul; 192(2):96-8. PubMed ID: 19596264
    [No Abstract]   [Full Text] [Related]  

  • 15. Focus on the epigenome in the myeloproliferative neoplasms.
    Kim E; Abdel-Wahab O
    Hematology Am Soc Hematol Educ Program; 2013; 2013():538-44. PubMed ID: 24319229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping.
    Sait SN; Qadir MU; Conroy JM; Matsui S; Nowak NJ; Baer MR
    Genes Chromosomes Cancer; 2002 May; 34(1):42-7. PubMed ID: 11921281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients.
    Higgins A; Mangaonkar AA; Hefazi M; Viswanatha D; Horna P; Foran J; Gangat N
    Leuk Res; 2018 Sep; 72():1-4. PubMed ID: 30055376
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization.
    Rayeroux KC; Campbell LJ
    Cancer Genet Cytogenet; 2009 Aug; 193(1):44-53. PubMed ID: 19602463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
    Ahmadi SE; Rahimi S; Zarandi B; Chegeni R; Safa M
    J Hematol Oncol; 2021 Aug; 14(1):121. PubMed ID: 34372899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline polymorphisms and the risk of therapy-related myeloid neoplasms.
    Takahashi K
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):24-30. PubMed ID: 30927971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.